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ABSTRACT Adenovirus infections in humans are common and sometimes lethal.
Adenovirus-derived vectors are also commonly chosen for gene therapy in human
clinical trials. We have shown in previous work that homologous recombination be-
tween adenoviral genomes of human adenovirus species D (HAdV-D), the largest
and fastest growing HAdV species, is responsible for the rapid evolution of this spe-
cies. Because adenovirus infection initiates in mucosal epithelia, particularly at the
gastrointestinal, respiratory, genitourinary, and ocular surfaces, we sought to deter-
mine a possible role for mucosal microbiota in adenovirus genome diversity. By
analysis of known recombination hot spots across 38 human adenovirus genomes in
species D (HAdV-D), we identiﬁed nucleotide sequence motifs similar to bacterial Chi
sequences, which facilitate homologous recombination in the presence of bacterial
Rec enzymes. These motifs, referred to here as ChiAD, were identiﬁed immediately 5=
to the sequence encoding penton base hypervariable loop 2, which expresses the
arginine-glycine-aspartate moiety critical to adenoviral cellular entry. Coinfection
with two HAdV-Ds in the presence of an Escherichia coli lysate increased recombina-
tion; this was blocked in a RecA mutant strain, E. coli DH5, or upon RecA depletion.
Recombination increased in the presence of E. coli lysate despite a general reduction
in viral replication. RecA colocalized with viral DNA in HAdV-D-infected cell nuclei
and was shown to bind speciﬁcally to ChiAD sequences. These results indicate that
adenoviruses may repurpose bacterial recombination machinery, a sharing of evolu-
tionary mechanisms across a diverse microbiota, and unique example of viral com-
mensalism.
IMPORTANCE Adenoviruses are common human mucosal pathogens of the gastro-
intestinal, respiratory, and genitourinary tracts and ocular surface. Here, we report
ﬁnding Chi-like sequences in adenovirus recombination hot spots. Adenovirus coin-
fection in the presence of bacterial RecA protein facilitated homologous recombina-
tion between viruses. Genetic recombination led to evolution of an important exter-
nal feature on the adenoviral capsid, namely, the penton base protein hypervariable
loop 2, which contains the arginine-glycine-aspartic acid motif critical to viral inter-
nalization. We speculate that free Rec proteins present in gastrointestinal secretions
upon bacterial cell death facilitate the evolution of human adenoviruses through ho-
mologous recombination, an example of viral commensalism and the complexity of
virus-host interactions, including regional microbiota.
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Human adenovirus (HAdV), now known to be both a common enteric and respira-tory pathogen (1, 2), was ﬁrst identiﬁed in 1953 from a child’s adenoid specimen
in organ culture (3, 4). A double-stranded DNA virus with a linear genome of ~35 kb,
HAdV segregates by phylogenomics to seven species (A to G), comprising 84 distinct
HAdV genotypes. The largest and most rapidly expanding HAdV species is HAdV
species D (HAdV-D) with 54 unique genotypes. Numerous HAdV-D types were ﬁrst
discovered in the feces of human patients with AIDS (5–10), and simultaneous coin-
fection with more than one adenovirus type is common (11, 12). Single nucleotide
polymorphisms in HAdV occur uncommonly, even over decades (13), and the 54 viruses
within HAdV-D are highly conserved (around 90% at the nucleotide level). However,
homologous recombination between viruses within HAdV-D occurs commonly, partic-
ularly at transitions from conserved to hypervariable nucleotide sequence where the
relatively high GC content of HAdV-D (~56% overall) drops abruptly (14). Remarkably,
every fully sequenced HAdV-D shows evidence for at least two prior homologous
recombination events among seven, stereotypically hypervariable, gene segments (14).
Taken together, these data suggest that adenoviruses can persistently infect the human
intestine, where coinfections set the stage for homologous recombination between
highly related genotypes.
The nonenveloped adenovirus capsid takes an icosahedral shape with 12 apices,
each marked by a trimeric ﬁber protein with its distal knob and encircled by ﬁve, linked
penton base proteins. Each individual penton base protein contains two hypervariable
loops (HVL1 and HVL2); HVL2 expresses the canonical arginine-glycine-aspartic acid
(RGD) moiety critical to integrin-mediated internalization of the virus (15, 16). Structural
data (17) shows that after binding of the ﬁber knob to one of several possible primary
receptors on the target cell, viral internalization is mediated through binding of each
RGD in the ﬁve-sided penton base capsomer to integrins, inducing in turn their
aggregation, conformational change, and autophosphorylation to catalyze down-
stream intracellular signaling. Previous analysis of hypervariable gene segments in 38
HAdV-Ds showed only 14 distinguishable amino acid patterns (proteotypes) (18) for
penton base HVL1 and only 10 for HVL2 (14), consistent with homologous recombi-
nation at penton base gene segments as a major driver in the ontogeny of new HAdV-D
types (19). Because HVL1 and HVL2 are separated by only 123 amino acids and yet their
coding regions recombine independently of one another (19), we predicted the exis-
tence of a recombination signal in the intervening, relatively conserved area of the
genome between the gene segments for these two hypervariable regions.
In bacteria and bacteriophage, a signal for recombination between homologous
DNA is the crossover hot spot instigator, or Chi nucleotide sequence. This was ﬁrst
discovered in bacteriophage lambda and then in bacterial DNA and later was shown to
mediate recombination between them (20). The Chi sequence in bacteriophage  and
in Escherichia coli (ChiEC) is 5=-GCTGGTGG-3= (21, 22), and its presence induces the
exonuclease function of the bacterial RecBCD enzyme (23). The RecA protein of E. coli
is then loaded onto unwound single-stranded DNA (ssDNA) by RecBCD to create an
ssDNA-protein ﬁlament, which invades homologous double-stranded DNA (dsDNA),
leading to homologous recombination (24). A conserved Chi sequence in bacterial
genera does not exist (25); the repair enzymes that repair dsDNA breaks and mediate
homologous recombination also differ in genera. However, RecA has signiﬁcant ho-
mology to eukaryotic Rad51 and its paralogs (26), enzymes that repair dsDNA breaks in
human cells, and facilitate homologous recombination in the human genome (27). Also,
the adenovirus and bacteriophage PRD1 exhibit striking structural similarities consis-
tent with a common ancestor (28), suggesting the possibility that mechanisms of phage
evolution have survived in the adenoviruses.
These disparate observations led us to consider whether the presence of intestinal
bacterial ﬂora during adenovirus coinfection might facilitate homologous recombina-
tion and evolution of enteric HAdV-Ds. Evidence for transkingdom interactions be-
tween bacteria of the human gut microbiome and enteric viruses has been accumu-
lating recently. In enteric infection with certain RNA viruses, virus hijacks surface
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bacterial glycans of normal bacterial ﬂora to gain entry to intestinal epithelial cells
(29–33). Recently, data suggesting that several enteric bacteria can promote recombi-
nation during poliovirus infection have appeared (34). As another common enteric
agent, adenoviruses are regularly shed in feces of humans and nonhuman primates for
months to years after infection (35–38), suggesting that adenoviruses might also
exploit enteric bacterial ﬂora to its own advantage. In the work described herein, we
utilized a previously published database of 38 whole HAdV-D genomes (14) to analyze
the GC/AT transition zone at the 5= end of penton base HVL2. We show the presence
of Chi-like sequences at the exact juncture of conserved and hypervariable sequence
and further show an increase in homologous recombination in the presence of bacterial
RecA protein. These data demonstrate a means by which bacterial ﬂora can facilitate
genetic exchange between adenoviruses.
RESULTS
We began by searching the penton base genes of HAdV-D for Chi nucleotide
sequences that, in bacteria and bacteriophage, act as signals for recombination be-
tween homologous DNA (20). By careful inspection, we identiﬁed Chi-like (ChiAD)
sequences, for example, 5=-TCTCCTGA-3= in HAdV-D37, in the relatively conserved
region immediately 5= to HVL2 (Fig. 1). We also noted that the nucleotide sequences of
putative ChiAD were generally conserved within proteotypes but not between them. In
other studies, patterned alterations of GC content in multiples of 15 nucleotides were
shown to facilitate homologous recombination between adjacent brome mosaic virus
ssRNAs through the formation of hairpin loops in the RNA (39, 40). Our computational
analysis of similar GC content transitions across whole HAdV-D genomes showed
comparable patterns of GC/AT transition at predicted recombination hot spots around
hypervariable gene segments in the three major capsid genes—the same segments
that constitute the molecular identity of each virus (14, 19, 41–43)—including the
region containing ChiAD immediately 5= to penton base HVL2 (see Fig. S1 and Ta-
ble S1 in the supplemental material). We applied mFold (http://unafold.rna.albany.edu/
?qmfold/dna-folding-form) to model the secondary structures of ssDNA surrounding
and including ChiAD, within the GC/AT transition zone at HVL2. The structures were
highly similar within proteotypes, less so between proteotypes (Fig. S2), suggesting
that patterned alterations in GC content generate secondary structures that facilitate
homologous recombination between HAdV-D types sharing the same ChiAD.
To examine the determinant(s) of homologous recombination among HAdV-Ds and
speciﬁcally the role of ChiAD, we generated constructs with the ChiAD-containing GC/AT
transition zones from the penton base genes of HAdV-D22 and -D64, both from the
same HVL2 proteotype (14), the former with the green ﬂuorescent protein (GFP) gene
without a promoter (D22GFP), and the latter with a CMVT7 (CMV stands for cytomeg-
alovirus) promoter inserted (D64CMV) (Fig. 2A). In 293A cells, cotransfection of linear-
ized D64CMV and D22GFP constructs resulted in GFP expression (Fig. 2B and C). By PCR
with primers speciﬁc to the recombinant product (Table S1) and subsequent sequenc-
ing, we conﬁrmed that the two constructs had indeed recombined at the expected
location (Fig. 2D and E), the same recombination locus often seen in HAdV-D recom-
bination in nature (19).
Prior work suggested that a single nucleotide change in Chi can reduce homologous
recombination events (44), with particular emphasis on the importance of the thymi-
dine (T) at the third position (45, 46). We generated targeted mutations in both
constructs to test the speciﬁcity of ChiAD at the single nucleotide level, while main-
taining homology between constructs for cotransfections. ChiAD nucleotide identities
were determined for HVL2 in each of 38 HAdV-Ds to determine a consensus sequence
(Fig. 2F). Mutants not found in any known virus were generated, and nine were selected
for testing, including one with nucleotide changes synonymous to D64/22 (SY), one
with reverse sequence (RE), one with antisense sequence (AS), and six randomly
selected. Mutating ChiAD reduced homologous recombination between vector con-
structs except for the SY mutant (Fig. 2G). Subsequent mFold analysis showed that the
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predicted secondary structure for the SY construct and the location of ChiAD in that
secondary structure were highly similar to those of the parent ChiAD (Fig. 2H). None of
the other predicted structures for ChiAD mutants were similar. The RE mutation, which
maintained T at the third position and was expected to undergo homologous recom-
bination, had a predicted secondary structure distinctly different from that of the
naturally occurring ChiAD. Therefore, nucleotide sequence and secondary structure may
be considered covariant determinants of homologous recombination.
The human gut microbiota includes trillions of bacteria and countless bacteriophage
(47). Their evolution is driven in part by Rec protein-mediated homologous recombi-
nation, speciﬁcally the unwinding of dsDNA by the RecBCD complex and upon recog-
nition of Chi, the loading of RecA onto the ssDNA (48). We quantiﬁed homologous
recombination between ChiAD constructs in the presence of an endotoxin-free lysate of
E. coli strain K-12 in comparison to a lysate from the K-12 RecA mutant strain DH5. By
trypan blue exclusion, bacterial cell lysates induced no cell toxicity (data not shown). As
predicted, the K-12 lysate promoted more homologous recombination between con-
structs than the DH5 lysate (Fig. 3A). The presence of RecA in lysates from each strain
FIG 1 Chi (ChiAD) nucleotide sequences in human adenovirus species D (HAdV-D). Thirty-eight HAdV-D
genomes were aligned by maximum likelihood analysis, a tree (left) was built based on the amino acid
sequences of penton base hypervariable loop 2 (HVL2), and the HAdV-D genomes were divided into
proteotypes as previously described (14), shown by a horizontal line separating the virus type names. The
30 nucleotides shown include the junction between conserved nucleotide sequence (black) and HVL2
nucleotide sequence (blue), with 15 nucleotides on either side of the junction. The ChiAD motifs (shown
on gray background) fall predominantly within the conserved sequence but include one nucleotide
within the hypervariable sequence.
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FIG 2 Modeling homologous recombination through ChiAD. (A) Constructs for in vitro recombination were generated on the pcDNA3.1-hygromycin/neomycin
by insertion of either the penton base gene of HAdV-D64 while retaining the hygromycin resistance gene or of HAdV-D22 with coding sequence for green
ﬂuorescent protein (GFP) without ATG site, no CMVT7 promoter, and retaining the neomycin resistance gene. HVL2 (yellow boxes), GC/AT transition zone (red
boxes with blue arrowhead above), CMVT7 promoter (gray boxes), and GFP open reading frames (green boxes) are indicated. EVH and EVN are hygromycin
and neomycin empty vectors minus their CMVT7 promoters, respectively. Modiﬁed vectors were linearized with NruI prior to transfection. (B) Fluorescence
microscopy for GFP expression in transfected 293A cells show green signal indicating recombination only when both HAdV-D sequence constructs are
cotransfected (right micrograph). Original magniﬁcation, 40. Bar, 25 m. (C) Fluorescent signal graphically represented relative to GFP with cotransfection of
an empty vector, demonstrating approximately threefold increase in signal upon cotransfection of ChiAD-containing constructs. The value that is signiﬁcantly
different (P  0.05) by ANOVA is indicated by an asterisk. (D) Conventional PCR performed on transfected 293A cells with primer pairs designed to amplify only
the hypothesized recombinant (forward primer from HAdV-D22 and a reverse primer for the CMVT7 promoter) shows a band only when both HAdV-D sequence
constructs are cotransfected and at the predicted 1.1-kb size. (E) Sanger sequencing of PCR product (from panel D) demonstrating the speciﬁc nucleotide
sequence predicted for the recombinant construct. (F) A consensus ChiAD sequence was generated in silico from 38 HAdV-Ds, and sequences not seen in known
viruses were then generated, including D64/22 synonymous (SY), reverse (RE), and antisense (AS) mutants, and six randomly chosen mutants. The consensus
nucleotides remaining in the chosen mutants are shown in red. (G) Fluorescent signal relative to GFP expression upon cotransfection of empty vector and
D22GFP show recombination with the constructs containing native ChiAD and also with a mutant (from panel F) containing synonymous changes to ChiAD (SY)
(*, P  0.05 by ANOVA). Each experiment was performed in triplicate and repeated three times. Error bars represent standard deviations of the means. (H)
Secondary ssDNA sequences as predicted by mFold, showing that the original ChiAD and SY mutants, which each recombined in panel G, have highly similar
predicted secondary structures.
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was conﬁrmed by Western blotting. To determine whether the effect was speciﬁc to
RecA, we also tested K-12 lysates from which we depleted RecA protein with immu-
nomagnetic beads and found that RecA-depleted K-12 lysate induced less recombina-
tion than lysate with mock depletion (Fig. 3B). We next examined the effects of lysates
from K-12, DH5, and RecA-depleted K-12 on penton base HVL2 recombination be-
tween two wild-type viruses with conserved ChiAD, HAdV-D19 and HAdV-D29, chosen
because of sufﬁcient sequence disparity in HVL1 and HVL2 to permit PCR discrimination
of recombinants. We coinfected both viruses in the intestinal adenocarcinoma cell line
Caco-2 (clone C2BBe1) and used conventional and quantitative PCR (qPCR) (Fig. 3C and
D, respectively) to identify recombination of penton base HVL2 between viruses. E. coli
K-12 lysate promoted recombination relative to phosphate-buffered saline (PBS), and to
a greater degree than either E. coli DH5 or RecA-depleted K-12, with the effect
statistically signiﬁcant by 7 days postinfection. The same results were evident in A549
cells, a lung carcinoma cell line (Fig. S3). Because an increase in viral replication due to
bacterial lysate could have accounted for the apparent increase in recombined viral
DNA (49), we also infected each cell type in the presence of K-12 lysate or PBS control
and performed qPCR with primers speciﬁc to sequence conserved between the hexon
genes of both viruses (Table S1). Relative to treatment with PBS, K-12 lysate appeared
to reduce but not prevent viral replication through 8 days postinfection in either cell
line (Fig. 4A to D). Upon coinfection and subsequent assay by qPCR, the recombinant
accounted for less than 0.1% of total viral DNA in either C2BBe1 (Fig. 4E) or A549 cells
(Fig. 4F). The relative increase in the ratio of recombinant viral DNA to total viral DNA
in the presence of K-12 lysate was maintained when total viral replication was taken
into account. Therefore, the absolute number of viral recombinants increased in the
presence of bacterial lysates despite a general inhibition of viral replication.
FIG 3 Promotion of homologous recombination by bacterial lysate in intestinal epithelial cells. (A) Quantiﬁcation of GFP expression by
ChiAD-containing constructs in the presence of a lysate of E. coli K-12 strain or its RecA mutant DH5 demonstrate reduced recombination in 293A
cells pretreated with RecA mutant (*, P  0.05 by Student’s t test). The Western blot below the graph shows expression of RecA in both E. coli
lysates and -galactosidase loading control. -RecA, anti-RecA antibody. (B) Expression of GFP in cotransfected 293A cells pretreated with either
E. coli K-12 lysate depleted of RecA (RecA-) by immunomagnetic beads, or unmodiﬁed K-12 lysate, showing reduction of recombination when
RecA is depleted (*, P 0.05 by Student’s t test). Western blot of depleted and native lysates is shown. (C) Conventional PCR performed on C2BBe1
cells pretreated with either PBS, E. coli K-12 lysate, DH5 lysate, or RecA-depleted K-12 lysate, and coinfected with HAdV-D19 and HAdV-D29, from
3 to 8 days postinfection (dpi). The PCR band generated by primers speciﬁc to the predicted recombinant (29F-19R, forward primer for HAdV-D29
HVL1 and reverse primer for HAdV-D19 HVL2) was greater in K-12 lysate-pretreated cells. Control PCR with primers that do not distinguish
recombinants from parent viruses is shown below (PentonF-R). (D) Quantitative PCR under the same treatment conditions in panel C shows
relative homologous recombination levels, as normalized to PBS-treated cells (*, P 0.05 by ANOVA). Each experiment was performed in triplicate
and repeated three times. Error bars represent standard deviations of the means.
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Adenovirus-infected cells at the time of viral replication have lost the capacity for
cellular biosynthesis, and these cells are in the early phases of virus-induced cell death
with reduced integrity to their cellular membranes (50). In addition, HAdV-D37 was
previously shown to release the ectodomain of MUC16 from ocular surface cells,
suggesting that adenoviruses may have intrinsic means of reducing overall mucosal
barrier function (51). We next performed confocal microscopy to determine whether
RecA would colocalize with viral DNA in infection of C2BBe1 cells (Fig. 5A). Coinfection
with 5-ethynyl-2=-deoxyuridine (EdU)-labeled HAdV-D19 and HAdV-D29 was performed
in the presence of E. coli K-12 lysate, and the cells were imaged at 12 h postinfection.
RecA protein was identiﬁed only in the nuclei of infected cells, where it colocalized with
FIG 4 Relative viral replication and recombination in the presence of bacterial protein. Using primers speciﬁc to hexon
sequence in HAdV-D19 (A and C) and HAdV-D29 (B and D), quantitative PCR was used to quantify total viral DNA from 1
to 8 days postinfection in PBS-treated versus E. coli K-12 lysate-treated C2BBe1 cells (A and B) and A549 cells (C and D).
DNA quantity is graphed relative to the levels at 1 day postinfection. (E and F) C2BBe1 (E) and A549 (F) cells pretreated
with PBS, K-12 lysate, DH5 lysate, or K-12 lysate depleted of RecA were coinfected with HAdV-D19 and HAdV-D29 and
subjected to quantitative PCR at 5 to 8 days postinfection, with primers chosen to amplify only the HVL2 recombinant.
Values that are signiﬁcantly different (P  0.05) by ANOVA are indicated by an asterisk. Each experiment was performed
in triplicate and repeated three times. Error bars represent standard deviations of the means.
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viral DNA. Confocal microscopy for the presence of RecB, RecC, and RecD similarly
showed nuclear colocalization of those proteins with viral DNA (Fig. S4). Healthy,
uninfected cells excluded Rec proteins. We next performed chromatin immunoprecipi-
tation (ChIP) 6 days after coinfection of C2BBe1 cells pretreated with K-12 lysate.
Binding of the IgG control was extremely low (data not shown), so we compared RecA
binding of HVL2 ChiAD with binding of RecA to conserved genomic regions without
ChiAD: one in protein VI and another at the conserved 3= end of the penton base gene.
RecA binding to penton base sequence containing ChiAD was ~14-fold greater than to
control regions of HAdV DNA (Fig. 5B). There are noncanonical pathways of RecA
loading that function in the absence of RecBCD in phage (52). To determine whether
RecBCD or other bacterial proteins are required for a putative interaction between RecA
and ChiAD, we repeated ChIP with recombinant RecA instead of E. coli lysate. The ratios
of binding to ChiAD relative to other regions of the genome were similar (Fig. 5B).
Relative to IgG, binding with K-12 lysate was twice that observed with recombinant
RecA (data not shown). These data show speciﬁcity of RecA binding to ChiAD and
suggest that RecBCD dispensably improves binding.
FIG 5 Binding of RecA to ChiAD in intestinal epithelial cells. (A) Confocal microscopy in C2BBe1 cells pretreated with E. coli K-12 lysate for 24 h and then either
mock infected or coinfected with EdU-labeled (red) HAdV-D19 and HAdV-D29. Samples were ﬁxed at 12 h postinfection and stained with DAPI (blue) and
anti-RecA (green). Stacked images without blue color are shown in the Merge panels (bars, 25 m). To reduce any artifact of perinuclear localization, a single
image centered on the nucleus in the inset with one image on either side is also shown in the Nucleus panels. Colocalization of viral DNA and RecA is suggested
by the yellow color. The small white boxes in the micrographs show the locations of the insets. Original magniﬁcation, 63. (B) ChIP analysis performed on
C2BBe1 cells pretreated with either E. coli K-12 lysate or recombinant RecA prior to coinfection with HAdV-D19 and HAdV-D29. Binding of RecA to ChiAD was
compared to IgG (not shown) and randomly chosen regions in protein VI (pVI) and penton base (Control). Binding afﬁnities were normalized to pVI binding
of RecA protein. Each experiment was repeated three times. Error bars represent standard deviations of the means. For each experiment, *, P 0.05 by ANOVA.
Lee et al.
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DISCUSSION
HAdV infects mucosal sites to cause a myriad of human diseases, and it can be lethal
in the immunocompromised host (53). How adenoviruses evolve is therefore of con-
siderable signiﬁcance, as new types can be associated with enhanced virulence and
pathogenicity. Single nucleotide substitutions in HAdV genomes are relatively slow to
accrue, with nucleotide-speciﬁc stability seen over decades (13, 54). In contrast, ho-
mologous recombination among circulating HAdV is widely recognized as the principal
means of their evolution (49, 55–62), and recombinational evolution of HAdV is now
codiﬁed in GenBank/NCBI criteria for typing newly emerging or historically known but
previously uncharacterized HAdV (63, 64). In HAdV-D, speciﬁc homologous recombina-
tion patterns predominate (14, 19, 41–43, 65–68). For example, homologous recombi-
nation involving the hypervariable region corresponding to penton base HVL2 is
particularly widespread (19), seen in almost every HAdV-D analyzed thus far. The
emergent HAdV-D53, now a common cause of severe epidemic keratoconjunctivitis
(69), expresses hexon epitopes of the nonpathogenic HAdV-D22, but the penton base
of HAdV-D37, a previously characterized and highly virulent eye pathogen (43). Another
eye pathogen, HAdV-D64, expresses the hexon epitopes of the nonpathogenic HAdV-
D19 on a genome “chassis” of HAdV-D37 with its penton base gene contributed by
HAdV-D22 (68). Homologous recombination is not restricted to HAdV-D. In HAdV-B55,
homologous recombination of the hexon gene hypervariable regions, prime determi-
nants of type-speciﬁc humoral immune responses, permitted the escape of a serious
respiratory pathogen from immune pressure (70–74).
Recombination between adenoviruses requires at least two homologous adenoviral
sequences, one an intact dsDNA and the other an ssDNA, as would be present in cells
undergoing viral DNA replication during coinfection (59, 60). Coinfection with two or
more HAdV types occurs commonly (12, 75, 76) and is tolerated by the host because
host immunity is mostly type speciﬁc (77). HAdV has been shown to cause persistent
infections of healthy persons (37) within secondary lymphoid tissues, including those at
Waldeyer’s ring (tonsils and adenoids), the gastrointestinal tract (4, 78–84), and even
the ocular surface (85). Viral persistence in infected tissues increases the likelihood of
coinfection with two or more adenoviruses. However, host factors that promote
recombination between HAdV genomes in vivo are unknown. Homologous recombi-
nation was ﬁrst identiﬁed by Lederberg and Tatum in 1946 (86) as a means to ensure
the viability of phage and bacteria under host and environmental selection pressures
and as a repair mechanism for dsDNA and ssDNA breaks during genome replication
(87–89). Homologous recombination between bacterial genomes is driven by the
presence of the ubiquitously expressed, bacterial RecA (38-kDa) protein, which is
loaded onto bacterial and phage DNA by the heterotrimer RecBCD or alternate Rec
proteins. RecA-mediated strand exchange (branch migration) occurs upon strict base
pairing between adjacent DNA molecules (90), and the recombination event can then
extend to include thousands of subsequent base pairs. Experimental null mutations in
E. coli RecA diminished bacterial recombination as much as 100,000-fold, while muta-
tions in the other Rec proteins had substantially lower effects (91), consistent with
known redundancy in the RecA loading function of RecBCD, but not in the recombi-
nation function of RecA. Although we showed a statistically signiﬁcant increase in viral
recombination in the presence of bacterial lysate, with reduced effect upon RecA
depletion, the impact on generation of new recombinant viral DNA was modest in
comparison to the known effect of RecA on bacteria and phage. If HAdV-Ds utilize
bacterial recombination machinery in vivo, they likely do so with considerably lower
efﬁciency than for bacteria and phage.
Chi sequences are typically 8 nucleotides long with a thymidine (T) at the third
position, but they differ in bacterial genera. Chi sequences appear more frequently than
would be expected by chance alone, suggesting their positive selection to facilitate
DNA repair and recombinational evolution (25). In bacteria and phage, the speciﬁc and
highly conserved nucleotide sequence for Chi is critical to its function, while in our
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experiments, ChiAD sequence speciﬁcity appeared considerably less stringent. Strictly
speaking, conﬁrmation of a canonical Chi-like effect of ChiAD will require further
experimental study (92). However, Chi-like sequences have been identiﬁed in human
immunodeﬁciency virus (93) and in human immunoglobulin and ABO genes (94, 95)
and implicated in translocation-associated human malignancies (96–99). We identiﬁed
Chi-like sequences in HAdV-D genomes (ChiAD) at a known recombination hot spot, just
5= to the sequence encoding penton base HVL2, the latter critical to viral internalization
and a presumed pathogenesis determinant. We showed in DNA constructs that ChiAD
sequence and directionality impact recombination, although not with the same degree
of sequence speciﬁcity as Chi in bacteria. Regardless, HAdV-D coinfection in the
presence of E. coli lysate increased recombination, not seen with a RecA mutant strain
or with RecA depletion, and RecA entered HAdV-infected cell nuclei where it localized
with viral DNA. Therefore, although RecA-mediated adenoviral recombination appears
to be less efﬁcient and less sequence speciﬁc than in bacteria and phage, it neverthe-
less appears that adenoviruses can beneﬁt from the recombination machinery of
resident bacterial ﬂora. While adenoviruses may exploit the recombination machinery
of local bacterial ﬂora, the efﬁciency of replication by the recombinant virus and
subsequent selection pressure by the host would determine whether a new recombi-
nant survives and is transmitted. In other words, postrecombination selection must also
play a role in the emergence of any new viruses. Regardless, our work is consistent with
the idea that human, bacterial, and viral genomes in the gut may utilize common
recombination machinery to foster microbial and viral diversity. It is also possible that
adenoviral recombination occurs during infection of other mucosal sites. For instance,
while the presence of a stable conjunctival microbiome is a matter of some conjecture
(100, 101), it is clear that bacterial superinfection coincident to adenovirus infection can
occur in epidemic keratoconjunctivitis (102, 103), which could conceivably promote
adenoviral recombination at the ocular surface.
Secondary structure is also known to impact recombination between two homolo-
gous nucleic acid molecules. Our analysis showed recombination in one construct (SY)
not predicted to undergo recombination, but the secondary structure and location of
ChiAD within that structure were highly similar to those of the parent ChiAD. Imputed
secondary structures were also found to be highly similar within but not between
penton base HVL2 proteotypes. In RNA viruses, stem-loop secondary structures were
shown to be particularly critical to recombination between two homologous ssRNA
(104–106). Adjacent regions that were 5= GC-rich and 3= AU-rich (39, 40) were consid-
erably more likely to recombine in brome mosaic virus (107), particularly when the
region of relatively greater GC content is followed by a greater AU-rich content of equal
length with preference for a GC/AU transition of 30, 45, or 60 nucleotides. The AU-rich
regions formed hairpin loops thought to induce a pause of the RNA replicase, followed
by template switching of the replicase (40, 108), i.e., polymerase jumping, when
loop-to-loop complementarity was also present (106). Polymerase hesitation due to
secondary loop structures was also shown to promote homologous recombination
between retroviruses (109, 110), poliovirus (111), norovirus (112), and coronavirus (113),
suggesting a common mechanism.
A relationship between a virus and local bacterial ﬂora could be detrimental to one
or both, beneﬁcial to one or both, or even obligate, with the outcome likely to shift over
time due to the dynamics of constantly changing host factors and environmental
inﬂuences. Commensalism characterizes a relationship between two disparate organ-
isms when one organism beneﬁts while the other is unaffected. Certain RNA viruses
beneﬁt by hijacking bacterial surface glycans in the gut to achieve host cell entry (29).
We propose a novel example of viral commensalism in which ChiAD sequences in the
HAdV-D genome are bound within infected cells by bacterial RecA, present because of
local bacterial ﬂora, to facilitate homologous recombination between viruses. Free Rec
proteins may be present in gastrointestinal secretions because of bacterial senescence
and loss of structural competency, competition and killing by other bacterial species
vying for the same mucosal niche, bacteriophage-mediated bacterial cell lysis, host
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inﬂammatory cells and factors induced by adenovirus infection that can lyse bacterial
cells, and/or the presence of endogenous antimicrobial peptides at the mucosal
surfaces (114–119). However, to characterize the relationship as commensal may be an
oversimpliﬁcation, as the interactions between adenoviruses, bacterial ﬂora, and the
host are certain to be multifaceted. For example, -defensins, peptides generated by
the host in response to microbes present in the gastrointestinal tract, limited adeno-
virus uncoating within endosomes (120, 121) and potentiated neutralizing antibody
responses to infection (122), but also enhanced viral entry into host cells (123). Our
work is another example of complexity in the dynamic evolution of virus-host interac-
tions, including the host’s microbiota.
MATERIALS AND METHODS
Cells, viruses, and bacteria. The 293A cell line was obtained from Thermo Fisher Scientiﬁc
(Waltham, MA) (R70507), and the A549 and Caco-2 (C2BBe1 clone) cell lines were obtained from ATCC
(Manassas, VA) (ATCC CCL-185 and ATCC CRL-2102). Cell lines were tested for and veriﬁed asMycoplasma
negative. Escherichia coli strain K-12 (ATCC 10798) was purchased from ATCC. E. coli strain DH5 was a
gift from Michael Gilmore at Massachusetts Eye and Ear Inﬁrmary, Harvard Medical School. HAdV-D19
(ATCC VR-1096) and HAdV-D29 (ATCC VR-1107) were purchased from ATCC and veriﬁed by molecular
typing of the major capsid genes. Viruses were puriﬁed using the cesium chloride gradient method,
veriﬁed as endotoxin negative, and the titers of the virus were determined by the tissue culture infectious
dose method.
GC/AT transitions and identiﬁcation of Chi-like motifs. HAdV-D gene segments of interest in 38
viruses of HAdV-D were organized by maximum likelihood trees, constructed using MEGA5 (http://www
.megasoftware.net/), and segregated into proteotypes by 10% difference in amino acid content and
conﬁrmed by simple inspection. Crossover hot spot instigator (Chi) sequences inside GC/AT transition
zones were identiﬁed by searching for 5=-NNTNNTNN-3= in which N could be any nucleotide. The same
38 viruses in HAdV-D were studied individually with the Recombination Site Pattern Finder (14). A
threshold of 10% difference in GC content was applied to identify regions of 30-, 45-, or 60-nucleotide
transition from GC rich to AT rich, with a sliding 15-nucleotide window. All GC/AT transition zones for 38
viruses were combined by matching nucleotide positions.
Cloning. The pcDNA3.1-hygromycin vector was obtained from Thermo Fisher Scientiﬁc, and the
hygromycin resistance gene replaced with one for neomycin from pcDNA3.1-myc-his-A() (Thermo
Fisher Scientiﬁc). The cytomegalovirus (CMV) and T7 promoters (pCVMT7) of both vectors were removed
using NruI-HF and NheI-HF, restriction enzymes from New England BioLabs (NEB, Ipswich, MA), and an
adaptor for Sanger sequencing (see Table S1 in the supplemental material) synthesized at Integrated
DNA Technologies (IDT) was cloned into the same region using T4 DNA ligase (NEB) to generate
pcDNA3.1-hygromycine/neomycin-NoCMVT7. Using Q5 Hot Start high-ﬁdelity DNA polymerase (NEB),
CMVT7 promoter and green ﬂuorescent protein (GFP) genes without start codon were ampliﬁed from
pcDNA3.1-hygromycin and pEGFP-N1 (EGFP stands for enhanced GFP) (TaKaRa, Mountain View, CA),
respectively. The CMVT7 promoter was inserted into the penton base gene of HAdV-D64 between
nucleotides 14414 and 14415, just after the GC/AT transition zone marking the transition from conserved
sequence to HVL2 (D64CMV). The GFP gene without a start codon was inserted into the penton base
gene of HAdV-D22 between nucleotides 15073 and 15074 (D22GFP). D64CMV and D22GFP were then
cloned into pcDNA3.1-hygromycin-NoCMVT7 and pcDNA3.1-neomycin-NoCMVT7 vectors, respectively.
ChiAD mutants were created on both pcDNA3.1-hygromycin-NoCMVT7-D64CMV and pcDNA3.1-
neomycin-NoCMVT7-D22GFP vectors using overlap extension PCR. All constructs were veriﬁed by Sanger
sequencing (Ocular Genomics Institute, Massachusetts Eye and Ear, Boston, MA).
Transfection and measurement of GFP signal. 293A cells were seeded on black 96-well cell culture
plates (Greiner Bio-One, Monroe, NC) in Dulbecco’s modiﬁed Eagle medium (DMEM), with 10% fetal
bovine serum (FBS) and 1% penicillin-streptomycin (Thermo Fisher Scientiﬁc). After incubation at 37°C in
5% CO2 for 24 h, 100 ng of each plasmid per well was transfected using Lipofectamine 3000 (Thermo
Fisher Scientiﬁc) according to the manufacturer’s instructions. At 2 days posttransfection, GFP expression
level in each well was measured on a SpectraMax M2 microplate reader (Molecular Devices, Sunnyvale,
CA) and visualized on a Leica SP5 confocal system (Leica Microsystems, Buffalo Grove, IL) with 40
magniﬁcation. For comparison of GFP expression levels in the presence of bacterial lysates, 293A cells
were treated with 1 g/well of either E. coli K-12, DH5, or RecA-depleted (RecA-) lysate for 24 h prior
to transfection.
PCR and quantitative PCR. PCR primers were synthesized by Integrated DNA Technologies (IDT)
(Coralville, IA), and these primers are shown in Table S1. Viral DNA was isolated using GeneJET viral
DNA/RNA puriﬁcation kit (Thermo Fisher Scientiﬁc) per the manufacturer’s instructions. DNA was
quantiﬁed and quality checked on a NanoDrop 2000C spectrophotometer (Thermo Fisher Scientiﬁc). PCR
was performed on a PTC-200 thermal cycler (Bio-Rad, Hercules, CA) with 1 ng of DNA, 12.5 l of GoTaq
G2 hot start green master mix (Promega, Madison, WI), and 30 ng of forward and reverse primer with
each primers in a total volume of 25 l. PCR was performed as follows: 95°C for 2 min; 35 cycles, with
1 cycle consisting of 95°C for 30 s, 60°C for 1 min, 72°C for 35 s, and 72°C for 5 min. Quantitative PCR
(qPCR) was performed on a QuantStudio 3 real-time PCR system (Thermo Fisher Scientiﬁc) with 1 ng of
DNA, 10 l of Fast Sybr green master mix (Thermo Fisher Scientiﬁc), and 20 ng of forward and reverse
primer with each primer in a total volume of 20 l. qPCR was performed as follows: 95°C for 20 s; 40
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cycles, with 1 cycle consisting of 95°C for 1 s and 60°C for 20 s with data collection and melting curve
analysis.
Secondary structure modeling. The mFold Web Server’s DNA folding form was used for DNA
secondary structure analysis and free energy measurements, without application of constraints, and set
for a linear DNA sequence with a folding temperature of 37°C. For default values, ionic conditions were
speciﬁed at 1 M sodium and no magnesium, maximum distance between paired bases as unlimited,
percent suboptimality number ﬁxed at 5, structure rotation angle set at auto, and regularization angle
at 0°.
E. coli lysate preparation and treatment. E. coli K-12 and DH5 were each inoculated into Luria
broth (LB), incubated at 37°C for 16 h in a shaking incubator at 225 rpm, then collected by centrifugation
in 50-ml conical tubes at 5,000 rpm for 10 min, and resuspended in 10 ml of phosphate-buffered saline
(PBS), and aliquots of the bacterial solutions were added to Lysing Matrix B tubes (MP Biomedicals, Santa
Ana, CA). Lysis was performed using a FastPrep-24 5G instrument (MP Biomedicals) at 6,000 rpm for six
45-s pulses. Endotoxin was extracted from bacterial lysates with Pierce High Capacity Endotoxin Removal
spin columns (Thermo Fisher Scientiﬁc). Protein concentrations were measured by Pierce BCA protein
assay kit (Thermo Fisher Scientiﬁc). Lysate was added to each well of six-well cell cultures at a ﬁnal
concentration of 50-g bacterial protein/ml of culture medium, i.e., 100 g/tissue culture well. For PBS
control, an equivalent volume of PBS was added to tissue culture medium per well. The presence of
endotoxin in bacterial lysates was ruled out using the ToxinSensor chromogenic LAL (Limulus amebocyte
lysate) endotoxin assay kit (GenScript, Piscataway, NJ); the ﬁnal endotoxin levels in cell culture medium
after the addition of bacterial lysates were below the detection limit of 0.005 endotoxin unit (EU)/ml.
RecA depletion from the E. coli K-12 strain was performed with magnetic beads. After E. coli was
vortexed for 1 min, 50-l aliquots of Dynabeads M-280 sheep anti-rabbit IgG (Thermo Fisher Scientiﬁc)
were added to 1.5-ml Eppendorf tubes and suspended in 1 ml of washing buffer consisting of 0.1%
bovine serum albumin (BSA) in magnesium- and calcium-free PBS. The tubes were placed in a MagJET
magnetic separation rack (Thermo Fisher Scientiﬁc) for 2 min, and then the wash buffer was removed.
Five hundred microliters of fresh wash buffer and 5 g of anti-RecA antibody (catalog no. ab63797;
Abcam, Cambridge, MA) were added to the beads, and after gentle mixing, the tubes were incubated at
4°C for 2 h in rotation. Control lysates (without RecA depletion) were treated with rabbit IgG isotype
control (catalog no. Ab37415; Abcam). The tubes were then placed in the magnetic separation rack for
2 min, and the supernatant was removed. The beads were washed with 1 ml of washing buffer three
times. Five hundred micrograms of E. coli K-12 lysate in 500 l was added and incubated at 4°C for 2 h
in rotation. After the tubes were placed in the magnetic separation rack for 2 min, the supernatant was
transferred into new tubes. Fifty microliters of elution buffer (0.1 M citrate [pH 2.3]) was added to the
beads and boiled for 5 min. The tubes were placed in the magnetic separation rack for 2 min, and the
buffer was transferred into new tubes. The protein concentration was measured by using the Pierce BCA
protein assay kit as described above, and 20-g portions were used for Western blotting with anti-RecA
(catalog no. MD-03-3; MBL International, Woburn, MA) and anti--galactosidase (catalog no. ab616;
Abcam).
Bacterial lysate toxicity was assessed by trypan blue exclusion; treatment of cell cultures with 50 g
bacterial lysate/ml of tissue culture medium for 1 week showed no cellular toxicity. C2BBe1 and A549
cells were seeded in six-well plates (Corning, Corning, NY). After 24-h incubation, 100 g in 50 l for each
bacterial lysate was added to 2 ml DMEM with 1% insulin-transferrin-selenium in each well for 24 h,
followed by coinfection with HAdV-D19 and HAdV-D29, each at a multiplicity of infection (MOI) of 0.001.
One hundred eighty microliters of supernatant was collected from 3 days postinfection (dpi) to 8 dpi.
Two units of DNase I (NEB) was treated with 20 l of 10 DNase I buffer at 37°C for 1 h, and then 2 l
of 0.5 M EDTA (pH 8.0) was added and incubated at 75°C for 10 min to inactivate DNase I, prior to viral
DNA isolation and PCR.
Confocal microscopy. C2BBe1 cells were cultured on four-well Nunc Lab-Tek chamber slides
(Thermo Fisher Scientiﬁc) for 24 h. Bacterial lysate was added to each well as described above for another
24 h prior to viral infection. 5-Ethynyl-2=-deoxyuridine (EdU)-labeled HAdV-D19 and HAdV-D29 were
prepared using Click-iT Plus EdU Alexa Fluor 555 imaging kit (Thermo Fisher Scientiﬁc) and added to each
well at an MOI of ~25 (for each virus) and incubated at 37°C in an incubator with 5% CO2 for 12 h. The
cells were washed three times with PBS, ﬁxed for 10 min in 300 l of 4% paraformaldehyde, washed three
times in PBS containing 2% BSA, treated with 300 l of permeabilization buffer (0.1% Triton X-100 in
washing buffer) for 10 min, and washed again. The Click-iT Plus reaction cocktail was added for 30 min
at room temperature, protected from light. After the cells were washed three times, 300 l of PBS
containing 2% BSA was added for 30 min for blocking. Primary antibodies were prepared as follows:
1:1,000 dilution for anti-RecA (MBL International) in washing buffer, 1:2,000 dilution for anti-RecB,
anti-RecC, and anti-RecD (gifts of Gerry Smith at Fred Hutchinson Cancer Research Center, Seattle, WA).
Three hundred microliters of each primary antibody was incubated with the cells for 1 h at room
temperature, protected from light. After the cells were washed three times, 300 l of 1:5,000 dilution in
washing buffer of secondary antibody was added to goat anti-mouse IgG-Alexa Fluor 488 conjugate
(Thermo Fisher Scientiﬁc) for anti-RecA and to goat anti-rabbit IgG-Alexa Fluor 488 conjugate (Thermo
Fisher Scientiﬁc) for anti-RecB, anti-RecC, and anti-RecD and incubated for 45 min at room temperature.
After three washes each in washing buffer and then in PBS, the cells were mounted with Vectashield
antifade mounting medium containing 4=,6=-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Bur-
lingame, CA). Photomicrographs were obtained on the Leica SP5 confocal system with 63 magniﬁca-
tion.
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Chromatin immunoprecipitation. C2BBe1 cells were seeded on 100-mm tissue culture dishes
(Greiner Bio-One) for 24 h, and 500 g of E. coli K-12 lysate was added for an additional 24 h. HAdV-D19
and HAdV-D29 were added to the cells at an MOI of 0.001, with bacterial lysate at the same concen-
tration. At 6 dpi, cells were collected by scraping into PBS, centrifuged, and washed twice in PBS. DNA
was extracted using a Pierce magnetic ChIP (chromatin immunoprecipitation) kit (Thermo Fisher Scien-
tiﬁc) per the manufacturer’s instructions, sheared with a Q700 sonicator (Qsonica, Newtown, CT) and then
treated with micrococcal nuclease (MNase). The sheared DNA was run on an agarose gel to conﬁrm DNA
fragments ranging between 200 and 1000 bp in length. ChIP assays were performed with anti-RecA
antibody (Abcam), using the same Pierce kit with qPCR primers as listed in Table S1.
Statistical analysis. All experiments were performed at least three times. Data were analyzed by
either Student’s t test for pairwise comparisons or by analysis of variance (ANOVA) with preplanned
comparisons, using SAS (Cary, NC). Signiﬁcance was set a priori at P  0.05.
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